Table 2.
Exposure | Pollutant | Health Endpoint | BI | RR | AP (%) | Excess cases | Attributable cases |
---|---|---|---|---|---|---|---|
Long-term | PM2.5 | Natural mortalitya | 479.3 | 1.062 (1.04-1.083) | 11.43% (7.61–14.86) | 683 (454–887) | 54.76 (36.46–71.2) |
COPD mortalitya | 11.63 | 1.09 (1.04-1.14) | 13.41% (8.08–19.84) | 19 (12–29) | 13.41 (8.08–19.84) | ||
LC mortalitya | 6.01 | IER function | 15.96% (7.61–23.22) | 2 (6–17) | 0.96 (0.46–1.4) | ||
IHD mortalityb | 90.99 | IER function | 15.15% (9.61–30.2) | 202 (128–403 | 13.78 (8.75–27.48) | ||
Stroke mortalityb | 28.87 | IER function | 13.1% (6.99–20.44) | 55 (30–86) | 3.78 (2.02–5.9) | ||
O3 | Respiratory mortalitya | 58.72 | 1.014% (1.005–1.024) | 0.04% (0.02–0.08) | 0 (0–1) | 0.03 (0.01–0.05) | |
Short-term | PM2.5 | Natural mortality | 479.3 | 1.014% (1.005–1.024) | 0.63% (0.23–1.02) | 38 (14–61) | 3.02 (1.11–4.91) |
O3 | 1.0029% (1.0014–1.0043) | 0.01% (0.0–0.01) | 1 (0–1) | 0.01 (0.0–0.01) |
aMortality for adults >30 years old; b mortality for adults >25 years’ old